Rate My Professor Marc-Emmanuel Dumas

Dumas is a Fellow of the Royal Society of Biology (FRSB) and the Royal Society of Chemistry (FRSC). His research specializes in systems medicine, focusing on metabolomics using 1H NMR spectroscopy and high-resolution mass spectrometry to study metabolite and lipid networks in metabolic and cardiorespiratory diseases, including type 2 diabetes, obesity, ischemic heart disease, and non-alcoholic fatty liver disease. He integrates multi-omics data including metabolomics, metagenomics, and transcriptomics to elucidate host-microbiome interactions and underlying biological mechanisms. Key publications include "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice" (Nature Medicine, 2017), "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity" (Gut, 2016), "Impact of the gut microbiota on inflammation, obesity, and metabolic disease" (Genome Medicine, 2016), and "Genetic mechanisms of critical illness in COVID-19" (Nature, 2021). Dumas heads Imperial's Microbiome Network and advances precision medicine through studies of microbiome-derived metabolites like trimethylamine N-oxide and hippurate.